Evidence map›Paper›PMID 38827525›Full record

ReviewFrontiers in cell and developmental biology2024

Vitrification of human blastocysts for couples undergoing assisted reproduction: an updated review.

Romualdo Sciorio, Luca Tramontano, Gerard Campos, Pier Francesco Greco, Giuseppe Mondrone, Anna Surbone, Ermanno Greco, Riccardo Talevi, Nicola Pluchino, Steven Fleming

Registry-linked trialAbstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07556601 (Clinical Validation of Ultra-rapid Blastocyst Vitrification), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07556601 narecruitingnot on this mapstarted 2026, after this paper: background citation

Clinical Validation of Ultra-rapid Blastocyst Vitrification: a Randomized Pilot Study in Oocyte Donation Cycles

TypeinterventionalSponsorFundacion DexeusRan2026 to 2028Enrolled80ConditionsInfertilityArmsStandard Vitrification, Ultra-Rapid Vitrification
3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Romualdo SciorioFertility Medicine and Gynaecological Endocrinology Unit, Department Woman Mother Child, Lausanne University Hospital, Lausanne, Switzerland.
Luca TramontanoDépartement de Gynécologie-Obstétrique, Réseau Hospitalier Neuchâtelois, Neuchâtel, Switzerland.
Gerard CamposFertility Geisinger Medical Center, Women's Health Fertility Clinic, Danville, PA, United States.
Pier Francesco GrecoVilla Mafalda, Centre for Reproductive Medicine, Rome, Italy.
Giuseppe MondroneIVF Research, Education, Development S.R.L., Caserta, Italy.
Anna SurboneFertility Medicine and Gynaecological Endocrinology Unit, Department Woman Mother Child, Lausanne University Hospital, Lausanne, Switzerland.
Ermanno GrecoVilla Mafalda, Centre for Reproductive Medicine, Rome, Italy.
Riccardo TaleviDipartimento di Biologia Strutturale e Funzionale, Universita' di Napoli 'Federico II', Complesso Universitario di Monte S, Napoli, Italy.
Nicola PluchinoFertility Medicine and Gynaecological Endocrinology Unit, Department Woman Mother Child, Lausanne University Hospital, Lausanne, Switzerland.
Steven FlemingDiscipline of Anatomy and Histology, School of Medical Sciences, University of Sydney, Sydney, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past 40 years there has been a worldwide critical change in the field of assisted reproduction technology (ART), leading to the increased application of single blastocyst transfer, which is extremely important to avoid the risks of multiple pregnancy and associated complications for both mother and babies. Indeed, advancements in ART over the last few decades have been obtained thanks to several improvements, including ovarian stimulation, embryo culture conditions and, of course, progress in cryopreservation methods, especially with the application of vitrification. The ability to cryopreserve human embryos has improved significantly with vitrification compared to the initially adopted slow-freezing procedures. Since the introduction of vitrification, it has become the gold standard method to effectively cryopreserve human blastocysts. However, some new protocols are now being explored, such as the short warming procedure and even shorter exposure to the equilibration solution before vitrification, which seem to provide optimal results. Therefore, the main aim of the current narrative review, will be to illustrate the benefit of vitrification as an effective method to cryopreserve the human blastocyst and to illustrate new protocols and variations which in future may increase the performance of vitrification protocols.

Indexed as

assisted reproductive technologyclinical pregnancy outcomeshuman blastocystsinfertilityslow-freezingvitrification

Identifiers

PMID38827525
PMCPMC11140474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.